Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma E Vincent

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|August 14, 2023
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation studyAndrei-Emil Constantinescu, Caroline J Bull, Nicholas Jones, et al.
Cancer Discovery|July 10, 2021
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell CarcinomaRomain Riscal, Caroline J Bull, Clementina Mesaros, et al.
Molecular Cell|October 17, 2015
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor GrowthEmma E Vincent, Alexey Sergushichev, Takla Griss, et al.
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
Nature Communications|October 29, 2024
Transcriptome-wide Mendelian randomization during CD4<sup>+</sup> T cell activation reveals immune-related drug targets for cardiometabolic diseasesXueyan Wu, Hui Ying, Qianqian Yang, et al.
Molecular Metabolism|October 21, 2025
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemiaFernando M Ponce-Garcia, Yasmin R Jenkins, Victoria D Assmann, et al.
Journal of the National Cancer Institute|September 23, 2025
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysisEmma Hazelwood, Lucy J Goudswaard, Matthew A Lee, et al.
Plos Medicine|February 3, 2022
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysisJames Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, et al.
Elife|December 21, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline Bull, Emma Hazelwood, Joshua A Bell, et al.
Journal of Leukocyte Biology|September 20, 2025
Transcriptome-wide Mendelian randomization exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|August 14, 2023
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation studyAndrei-Emil Constantinescu, Caroline J Bull, Nicholas Jones, et al.
Cancer Discovery|July 10, 2021
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell CarcinomaRomain Riscal, Caroline J Bull, Clementina Mesaros, et al.
Molecular Cell|October 17, 2015
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor GrowthEmma E Vincent, Alexey Sergushichev, Takla Griss, et al.
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
Nature Communications|October 29, 2024
Transcriptome-wide Mendelian randomization during CD4<sup>+</sup> T cell activation reveals immune-related drug targets for cardiometabolic diseasesXueyan Wu, Hui Ying, Qianqian Yang, et al.
Molecular Metabolism|October 21, 2025
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemiaFernando M Ponce-Garcia, Yasmin R Jenkins, Victoria D Assmann, et al.
Journal of the National Cancer Institute|September 23, 2025
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysisEmma Hazelwood, Lucy J Goudswaard, Matthew A Lee, et al.
Plos Medicine|February 3, 2022
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysisJames Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, et al.
Elife|December 21, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline Bull, Emma Hazelwood, Joshua A Bell, et al.
Journal of Leukocyte Biology|September 20, 2025
Transcriptome-wide Mendelian randomization exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Pageof 8